Credit Suisse Ag Becton Dickinson & CO Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Becton Dickinson & CO stock. As of the latest transaction made, Credit Suisse Ag holds 404,469 shares of BDX stock, worth $92.4 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

404,469

Previous 467,907 13.56%

Holding current value

$92.4 Million

Previous $114 Million 12.27%

% of portfolio

0.1%

Previous 0.11%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$233.45 - $247.73 $14.8 Million - $15.7 Million	-63,438 Reduced 13.56%	404,469 $100 Million
Q4 2023 Feb 08, 2024	BUY	$232.24 - $267.23 $4.19 Million - $4.82 Million	18,041 Added 4.01%	467,907 $114 Million
Q3 2023 Nov 13, 2023	SELL	$254.9 - $283.59 $1.15 Million - $1.28 Million	-4,497 Reduced 0.99%	449,866 $116 Million
Q2 2023 Aug 11, 2023	BUY	$238.39 - $265.32 $2.06 Million - $2.29 Million	8,642 Added 1.94%	454,363 $120 Million
Q1 2023 May 10, 2023	BUY	$229.71 - $259.35 $435,530 - $491,727	1,896 Added 0.43%	445,721 $110 Million
Q4 2022 Feb 13, 2023	BUY	$218.29 - $256.91 $7.03 Million - $8.28 Million	32,212 Added 7.83%	443,825 $113 Million
Q3 2022 Nov 10, 2022	SELL	$51.03 - $264.23 $1.78 Million - $9.19 Million	-34,788 Reduced 7.79%	411,613 $91.7 Million
Q2 2022 Aug 12, 2022	SELL	$234.74 - $275.42 $25.8 Million - $30.2 Million	-109,817 Reduced 19.74%	446,401 $110 Million
Q1 2022 May 16, 2022	BUY	$243.64 - $270.48 $22.1 Million - $24.5 Million	90,596 Added 19.46%	556,218 $148 Million
Q4 2021 Feb 14, 2022	SELL	$230.08 - $250.94 $2.42 Million - $2.64 Million	-10,505 Reduced 2.21%	465,622 $117 Million
Q3 2021 Nov 12, 2021	SELL	$232.72 - $256.47 $2 Million - $2.2 Million	-8,574 Reduced 1.77%	476,127 $117 Million
Q2 2021 Aug 16, 2021	SELL	$232.65 - $254.58 $21.6 Million - $23.6 Million	-92,645 Reduced 16.05%	484,701 $120 Million
Q1 2021 May 14, 2021	BUY	$232.09 - $256.88 $3.38 Million - $3.74 Million	14,578 Added 2.59%	577,346 $140 Million
Q4 2020 Feb 12, 2021	BUY	$221.92 - $245.94 $1.5 Million - $1.66 Million	6,756 Added 1.22%	562,768 $141 Million
Q3 2020 Nov 13, 2020	BUY	$215.77 - $276.76 $3.9 Million - $5 Million	18,052 Added 3.36%	556,012 $129 Million
Q2 2020 Aug 12, 2020	SELL	$219.9 - $263.41 $3.06 Million - $3.67 Million	-13,929 Reduced 2.52%	537,960 $129 Million
Q1 2020 May 13, 2020	SELL	$195.69 - $279.01 $5.08 Million - $7.25 Million	-25,981 Reduced 4.5%	551,889 $127 Million
Q4 2019 Feb 12, 2020	BUY	$236.45 - $266.82 $20.1 Million - $22.7 Million	85,185 Added 17.29%	577,870 $157 Million
Q3 2019 Nov 12, 2019	BUY	$230.58 - $256.08 $689,434 - $765,679	2,990 Added 0.61%	492,685 $125 Million
Q2 2019 Aug 14, 2019	BUY	$217.4 - $246.08 $377,841 - $427,687	1,738 Added 0.36%	489,695 $123 Million
Q1 2019 May 14, 2019	SELL	$206.05 - $248.17 $2.94 Million - $3.55 Million	-14,286 Reduced 2.84%	487,957 $122 Million
Q4 2018 Feb 13, 2019	BUY	$204.73 - $257.93 $7.19 Million - $9.05 Million	35,104 Added 7.51%	502,243 $113 Million
Q3 2018 Nov 13, 2018	BUY	$233.07 - $256.0 $6.58 Million - $7.23 Million	28,234 Added 6.43%	467,139 $122 Million
Q2 2018 Aug 14, 2018	SELL	$208.1 - $233.85 $20.1 Million - $22.6 Million	-96,772 Reduced 18.07%	438,905 $105 Million
Q1 2018 May 15, 2018	BUY	$205.46 - $240.27 $8.3 Million - $9.71 Million	40,406 Added 8.16%	535,677 $116 Million
Q4 2017 Feb 14, 2018	BUY	$189.0 - $222.64 $11.8 Million - $13.9 Million	62,654 Added 14.48%	495,271 $106 Million
Q3 2017 Nov 14, 2017	SELL	$186.89 - $198.9 $2.22 Million - $2.37 Million	-11,892 Reduced 2.68%	432,617 $84.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	444,509	444,509 $86.7 Million

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account